New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Dr. Michael Okun, director of the Fixel Institute for Neurological Diseases at the University of Florida and medical adviser to the Parkinson’s Foundation, says that Parkinson’s disease might ...

This work was supported by a grant from the NIH. Okun reported relationships with the NIH, Michael J. Fox Foundation, Parkinson's Foundation, Parkinson Alliance, Smallwood Foundation, UF ...

A woman who can smell Parkinson’s disease is using her hyperosmia — an enhanced sense of smell — to help diagnose the degenerative disease early as part of a study funded by the Michael J ...

Parkinson's disease, she said, "affects my chin and my throat, everything. It's hard for me to swallow, and it's hard for me to talk." She volunteered to be the first aDBS patient at UCHealth ...

And the Michael J. Fox Foundation, now in its 25th year, is a leader in Parkinson’s research, funding over $2 billion in studies and accelerating 19 new treatments to market.

Many patients with Parkinson's Disease do not have the right specialists diagnosing and treating them because the U.S. has only around 660 movement disorder specialists.

Genetic mutations are linked to about 10 to 15 percent of Parkinson’s diagnoses, said Dr. Michael S. Okun, ... L-dopa, or Levodopa, is still a mainstay treatment for Parkinson’s disease, ...